Eton Pharmaceuticals, Inc. (ETON) › Capital ExpendituresEton Pharmaceuticals, Inc. (ETON) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $236.0K2019: $1.10M2020: $50.0K2021: $9.0K2022: $38.0K2023: $02024: $26.0K2025: $333.0K$333.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$333.0K+1180.8%2024$26.0K—2023$0-100.0%2022$38.0K+322.2%2021$9.0K-82.0%2020$50.0K-95.4%2019$1.10M+364.4%2018$236.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share